药房零售市场(主要地区、市场参与者、规模和份额)- 2031 年预测

  • Report Code : TIPRE00027702
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

预计 2023 年至 2031 年药店零售市场的复合年增长率为 10.5%,市场规模将从 2023 年的 XX 百万美元扩大到 2031 年的 XX 百万美元。

报告按类型(处方药和非处方药 (OTC))、疾病类型(慢性、急性和其他)、销售类型(零售市场、医院和医生)细分

报告目的

Insight Partners 发布的《药店零售市场》报告旨在描述当前形势和未来增长、主要驱动因素、挑战和机遇。这将为各种业务利益相关者提供见解,例如:

  • 技术提供商/制造商:了解不断变化的市场动态并了解潜在的增长机会,从而能够做出明智的战略决策。
  • 投资者:对市场增长率、市场财务预测以及整个价值链中存在的机会进行全面的趋势分析。
  • 监管机构:监管市场政策和警察活动,旨在最大限度地减少滥用行为,维护投资者的信任和信心,维护市场的完整性和稳定性。

 

药店零售市场细分

 

类型

  • 处方药
  • 非处方药

疾病类型

  • 慢性的
  • 急性
  • 其他的

销售类型

  • 零售市场
  • 医院与医生

地理

  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

地理

  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

 

定制此报告以满足您的需求

您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣

药店零售市场:战略洞察

Pharmacy Retailing Market
  • 获取此报告的关键市场趋势。
    这个免费样品将包括数据分析,从市场趋势到估计和预测。

 

药店零售市场增长动力

  • 非处方药 (OTC) 需求不断增长:非处方药 (OTC) 需求不断增长,这实际上为药店零售业带来了火上浇油。如今,大多数客户都希望在没有医生处方的情况下服用药物来治疗简单的疾病,这推动了消费者对药店销售的消费,并增加了消费者友好型医疗保健解决方案的零售客流量,从而带来市场增长和更多的收入潜力。
  • 药店零售业的演变:与药店相结合的技术。它进一步推进了面向公众的自动配药系统、移动医疗应用程序和远程药房服务。这些不仅使客户在药店的体验更有价值,而且还鼓励改进库存管理和客户参与度,使药店零售业成功繁荣。
  • 将健康和保健放在首位:这是决定药店零售市场增长的趋势。消费者主动关注自己的健康,似乎不仅在药物方面,而且在补充剂、健康相关产品和预防保健方面也很注重健康。因此,趋势正在发生变化,这将导致药店的终结,但这并不可避免,因为他们试图扩大产品供应,适应不断变化的消费者议程,成为健康和保健中心。

药店零售市场未来趋势

  • 转向在线药房服务的趋势:这是引领药房零售市场转向在线药房服务的主要趋势之一。现在,电子药房越来越受到客户的欢迎,他们无需离开家去药房就可以浏览处方药、非处方药和保健产品,这种变化因 COVID-19 疫情而加速,当时非接触式和远程医疗保健成为强制性要求,并且由于数字药房平台的迅猛发展,需求激增。
  • 扩大健康和保健产品线:现有产品包括药店提供的产品,其中包括膳食补充剂、维生素和个人护理产品等健康和保健产品。这符合消费者对健康和预防保健的需求。一站式购买一般处方保健产品越来越受到消费者的欢迎,药店的收入也超出了处方药的范畴。
  • 采用先进技术提升客户体验:客户将体验到全新的互动阶段。其中一项高度先进的技术正在逐步淘汰药店零售,客户体验的所有标志性元素都将提升到更高的维度。这种趋势是引入人工智能聊天机器人进行虚拟咨询,以及使用移动应用程序通过自助服务亭补充处方。这很可能将为更顺畅的流程建立便利性和可访问性,以更高效地响应客户需求,从而提高竞争激烈的市场地位的满意度和卓越性。

药店零售市场机会

  • 扩大健康和保健服务:药店零售在健康和保健服务方面还有改进空间。药店可以通过提供血压监测、疫苗接种、健康咨询,甚至健身和饮食咨询等服务,定位为完整的健康中心。这些健康服务可能会吸引注重健康生活的潜在消费者,同时满足日益增长的预防性医疗保健需求。这种方法通常会增加收入来源,最糟糕的是,还会增加客户忠诚度,使药店成为公共卫生管理中更重要的合作伙伴。
  • 个性化医疗的增加和数字医疗的增长:然而,药店零售业的最佳机会在于个性化医疗和数字医疗工具。此类解决方案必须使药店服务适应个性化护理计划、基因检测和远程健康监测,这些都可以通过合作伙伴关系或店内服务提供。消费者只想要高度个性化的医疗保健,因此顺应这一趋势将有助于提高药店的价值并扩大药店的影响力。
  • 与医疗保健提供商建立战略合作伙伴关系:药店有机会与医疗保健提供商建立战略合作伙伴关系,以缩小药店与初级保健之间的差距。发展和提供药店与诊所以及医院患者之间的合作伙伴关系以及远程医疗服务将改善对患者的整个护理过程,鼓励患者坚持服药并进一步改善健康状况。因此,它将使转型后的药店成为战略医疗保健合作伙伴,并提高客流量和销售额。

 

药店零售市场区域洞察

Insight Partners 的分析师已详尽解释了预测期内影响药店零售市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的药店零售市场细分和地理位置。

Pharmacy Retailing Market
  • 获取药店零售市场的区域特定数据

药店零售市场报告范围

报告属性细节
2023 年的市场规模XX 百万美元
2031 年市场规模XX 百万美元
全球复合年增长率(2023 - 2031)10.5%
史料2021-2022
预测期2024-2031
涵盖的领域按类型
  • 处方药
  • 非处方药
按疾病类型
  • 慢性的
  • 急性
  • 其他的
按销售类型
  • 零售市场
  • 医院与医生
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 阿波尔药房私人有限公司
  • Emami Frank Ross 有限公司
  • 全球健康热线私人有限公司
  • 卫报生命护理私人有限公司
  • MedPlus 健康服务私人有限公司
  • 网医市场有限公司
  • 喜马拉雅药业私人有限公司

 

药店零售市场参与者密度:了解其对业务动态的影响

药店零售市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。

市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。

在药店零售市场运营的主要公司有:

  1. 阿波尔药房私人有限公司
  2. Emami Frank Ross 有限公司
  3. 全球健康热线私人有限公司
  4. 卫报生命护理私人有限公司
  5. MedPlus 健康服务私人有限公司

免责声明上面列出的公司没有按照任何特定顺序排列。


Pharmacy Retailing Market

 

  • 获取药店零售市场顶级关键参与者概述

 

 

主要卖点

 

  • 全面覆盖:报告全面涵盖了药房零售市场的产品、服务、类型和最终用户的分析,提供了整体概况。
  • 专家分析:报告基于对行业专家和分析师的深入了解而编写。
  • 最新信息:该报告涵盖了最新信息和数据趋势,确保了其与业务的相关性。
  • 定制选项:此报告可以定制以满足特定客户要求并恰当地适应业务策略。

因此,药店零售市场研究报告有助于引领解读和了解行业情景和增长前景。尽管可能存在一些合理的担忧,但本报告的总体优势往往大于劣势。

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the expected CAGR of the pharmacy retailing market?

  The pharmacy retailing market is estimated to grow with a CAGR of 10.5% from 2023 to 2031.

Which region is expected to witness fastest growth rate by 2031?

Asia Pacific region is likely to witness fastest growth rate during the forecast period.

What are the driving factors impacting the pharmacy retailing market?

The market drivers include rising demand for over-the-counter (OTC) medications and pharmacy retailing evolution are driving the pharmacy retailing market

Which are the leading players operating in the pharmacy retailing market?

The pharmacy retailing market majorly consists of the players such as Apoll Pharmacy Private Limited, Emami Frank Ross Limited among others.

What are the future trends of the pharmacy retailing market?

Shifting trends towards online pharmacy services are likely to remain the key trend during the forecast period

Which region dominated the pharmacy retailing market in 2023?

North America dominated the pharmacy retailing market in 2023

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies

1.Apoll Pharmacy Private Limited
2.Emami Frank Ross Limited
3.Global Healthline Private Limited
4.Guardian Lifecare Private Limited
5.MedPlus Health Services Private Limited
6.Netmeds Marketplace Limited
7.The Himalaya Drug Company Private Limited

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.